Skip to content

A study to evaluate spinal dexmedetomidine in patients undergoing laproscopic surgeries under general anesthesia

A STUDY TO EVALUATE THE EFFICACY OF INTRATHECAL DEXMEDETOMIDINE IN PATIENTS UNDERGOING LAPROSCOPIC SURGERIES UNDER CONVENTIONAL GENERAL ANAESTHESIA

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2020/11/028924
Enrollment
74
Registered
2020-11-05
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: K801- Calculus of gallbladder with othercholecystitis Health Condition 2: K802- Calculus of gallbladder without cholecystitis

Interventions

Intervention1: Dexmedetomidine: Alpha 2 receptor agonist. Intrathecal dexmedetomidine 5 microgram (0.05ml) diluted with 0.5ml cerebrospinal fluid followed by conventional genera anesthesia. Control In

Sponsors

Bangalore Medical college and research institute
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: 1) Patients willing to give informed written consent 2) ASA physical status I and II patients 3) Patients of age group 18-55 years, of either sex 4) Patients undergoing elective laparoscopic surgeries under general anaesthesia 5) Patients with Body Mass Index between 18 to 30 kg/m2

Exclusion criteria

Exclusion criteria: 1) Patients with contraindications to spinal technique 2) Patients with known allergy to dexmeditomedine 3) Patients with cardiovascular and respiratory diseases

Design outcomes

Primary

MeasureTime frame
hemodynamic stabilityTimepoint: Intraoperative period

Secondary

MeasureTime frame
1.Consumption of volatile inhalational agent. 2. Time to first rescue analgesic and duration of post-operative analgesia 3. Post-operative sedation 4.Frequency of post-operative nausea and vomiting 5. Other complications if any.Timepoint: postoperative period

Countries

India

Contacts

Public ContactJayadev S Baglekar

Banglore Medical College and Research Institute

doc.blossoms@gmail.com9742441267

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026